TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vitrolife AB
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
3,512,000
|
3,234,000
|
1,680,804 |
| Financial expenses |
142,000
|
119,000
|
10,747 |
| Earnings before taxes |
-3,712,000
|
537,000
|
459,969 |
| EBITDA |
1,117,000
|
1,050,000
|
507,956 |
| Total assets |
16,329,000
|
20,551,000
|
19,428,796 |
| Current assets |
1,914,000
|
1,573,000
|
1,406,601 |
| Current liabilities |
557,000
|
621,000
|
954,326 |
| Equity capital |
12,722,000
|
16,736,000
|
15,322,175 |
| - share capital |
28,000
|
28,000
|
27,631 |
| Employees (average) |
1,084
|
1,117
|
478 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
77.9%
|
81.4%
|
78.9% |
| Turnover per employee |
3,240
|
2,895
|
3,516 |
| Profit as a percentage of turnover |
-105.7%
|
16.6%
|
27.4% |
| Return on assets (ROA) |
-21.9%
|
3.2%
|
2.4% |
| Current ratio |
343.6%
|
253.3%
|
147.4% |
| Return on equity (ROE) |
-29.2%
|
3.2%
|
3.0% |
| Change turnover |
278,000
|
1,553,196
|
435,232 |
| Change turnover % |
9%
|
92%
|
35% |
| Chg. No. of employees |
-33
|
639
|
73 |
| Chg. No. of employees % |
-3%
|
134%
|
18% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.